At least if the company liquidates, you will have a loss you can offset against any gains, that's probably worth more than the value of the shares if the deal goes ahead. (Not financial advice, just something to take into consideration).
- Forums
- ASX - By Stock
- CCE
- Ann: Dispatch of Prospectus
Ann: Dispatch of Prospectus, page-11
Featured News
Add CCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $15.01M |
Open | High | Low | Value | Volume |
4.1¢ | 4.1¢ | 4.0¢ | $945 | 23.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 94782 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 5785 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 94782 | 0.040 |
1 | 221317 | 0.039 |
5 | 739854 | 0.038 |
3 | 161047 | 0.036 |
3 | 35786 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 5785 | 3 |
0.042 | 12547 | 1 |
0.043 | 129423 | 2 |
0.044 | 105000 | 2 |
0.045 | 73555 | 3 |
Last trade - 12.08pm 13/11/2024 (20 minute delay) ? |
Featured News
CCE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online